Navigation Links
Antihistamine Could also be used as a Potential Antimalarial Drug

Researchers have found that astemizole, which is used for treating allergy can also be used as a potential drug for treating malaria//.

According to a study conducted by researchers from the Johns Hopkins Bloomberg School of Public Health and the Johns Hopkins University School of Medicine. The study, largely funded by the Johns Hopkins Malaria Research Institute (MRI), determined that in a test tube the antihistamine killed the parasite, Plasmodium falciparum, which causes malaria in humans, including parasite strains that were resistant to traditional malaria therapies. The drug was also shown to be effective in mouse models. The findings are published in the July 2, 2006, advanced online edition of Nature Chemical Biology.

“Time and money are major roadblocks when it comes to developing new drugs for the treatment of neglected diseases like malaria,” said senior study author David Sullivan, MD, an associate professor with MRI and the Bloomberg School’s W. Harry Feinstone Department of Molecular Microbiology and Immunology. “Astemizole is promising as an antimalarial, but still needs to be evaluated for effectiveness as an antimalarial in humans.”

For the study, Sullivan and colleagues Curtis Chong and Jun Liu of the Johns Hopkins School of Medicine’s Department of Pharmacology first assembled the Johns Hopkins Clinical Compound Library, which is a collection of 2,687 drugs. Seventy percent of the compounds are approved by the U.S. Food and Drug Administration, while the remaining 30 percent are approved by regulatory agencies in other countries. The researchers screened the drugs for their effectiveness in killing the malaria-causing parasite and found that astemizole was one of the more promising.

The researchers then gave astemizole, along with the drug’s major human metabolite, desmethylastemizol, to mice infected with Plasmodium. They measured 80 percent reduction in parasite counts with moderate doses of drug in chloroquine-sensitive mice and 40 percent reductions in chloroquine-resistant mice. Higher doses completely eliminated Plasmodium infection.

Astemizole was voluntarily withdrawn from the U.S. and European markets in 1999 after 15 years of use when sales became sluggish after warnings about the drug’s safety and the introduction of newer antihistamines. The drug was reported to cause rare, but life-threatening heart arrhythmias when patients took an overdose or with drugs that affected its metabolism. However, arrhythmias are also reported with existing malaria drugs and other antihistamines now sold over the counter. Astemizole is currently still used in 30 countries, including Cambodia, Thailand and Vietnam where malaria is endemic.

Human studies are planned to evaluate the effectiveness of astemizole directly in asymptomatic malaria patients, a process that will be accelerated by the fact that the medication has been through an approval process. The researchers hope to next validate this new drug class for use in combination with existing malaria drugs like artemisinin or the quinolines.

The Johns Hopkins Clinical Compound Library will now be available to screen existing drugs for new uses for diseases affecting the developing world. “This line of research can be applied to many neglected diseases,” said Chong, the lead author of the study.

(Source: Nwswise)
'"/>




Related medicine news :

1. Nasal Spray Beats Antihistamine
2. Antihistamine Proved Ineffective in Making Kids to Sleep
3. Travelers’ Hazard- Antihistamines Make Drowsy Driver
4. Lean Protein Could Be Key to Obesity Drugs
5. Nasal Spray Could Take Drugs Direct to Brain.
6. Nasal Spray Could Take Drugs Directly to Brain
7. Oxygen Usage During Exercise Could Indicate Heart Problems
8. Ultrasound Screening Could Improve The Outcome Of Critically ill Patients
9. Anger Could Be Linked To Weight Gain
10. A Seizure Late In Life Could be A Stroke Warning
11. New Findings Could Reduce The Extent Of Spinal Cord Injuries
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... , ... October 13, 2017 , ... The Visiting Nurse ... Market. Featuring a collection of specialty vendors and unique items from across the nation, ... quality-focused health and wellness services offered by the VNA. The boutique will be ...
(Date:10/13/2017)... VA (PRWEB) , ... October 13, 2017 , ... ... of DevOps and Agile Software Development, has been awarded a contract by the ... Blanket Purchase Agreement (BPA) aims to accelerate the enterprise use of Agile methodologies ...
(Date:10/12/2017)... New Orleans, LA (PRWEB) , ... October 12, 2017 , ... ... fitness centers in the U.S., announced today its plans to open a flagship location ... club will occupy the former Rooms To Go store next to Office Depot in ...
(Date:10/12/2017)... , ... October 12, 2017 , ... ... delivery system that we intend to develop to enable prevention of a major ... to severe hearing loss, especially in pediatric patients. For cisplatin, hearing loss is ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... been named one of Michigan’s 2017 Best and Brightest in Wellness® by Best ... in Wellness® awards program on Friday, Oct. 20 from 7:30 a.m. to 2 ...
Breaking Medicine News(10 mins):
(Date:10/11/2017)... , Oct. 11, 2017  BioPharmX Corporation (NYSE MKT: ... that developed an innovative way to use nonlinear optical ... delivery of new drugs. ... Dermatology Conference will show how researchers from BioPharmX and ... Medical School used a suite of imaging techniques in ...
(Date:10/11/2017)... 11, 2017  True Health, a leader in ... effort during National Breast Cancer Awareness month to ... Research recently ... that more than 10 million American women are ... BRCA1 or BRCA2 and have not had testing. These ...
(Date:10/10/2017)... -- NDS received FDA 510(k) clearance in May 2017 for its highly ... designed for endoscopy environments. An innovative secondary monitor solution, ZeroWire ... support the improvement of patient outcomes, procedural efficiency, and the lowering ... ... ...
Breaking Medicine Technology: